-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Abivax, Maintains $175 Price Target

Benzinga·09/22/2026 15:30:01
語音播報
BTIG analyst Julian Harrison reiterates Abivax (NASDAQ:ABVX) with a Buy and maintains $175 price target.